Pim Gal

1.1k total citations
60 papers, 771 citations indexed

About

Pim Gal is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Pim Gal has authored 60 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Pim Gal's work include Atrial Fibrillation Management and Outcomes (20 papers), Cardiac electrophysiology and arrhythmias (20 papers) and Cardiac Arrhythmias and Treatments (15 papers). Pim Gal is often cited by papers focused on Atrial Fibrillation Management and Outcomes (20 papers), Cardiac electrophysiology and arrhythmias (20 papers) and Cardiac Arrhythmias and Treatments (15 papers). Pim Gal collaborates with scholars based in Netherlands, United States and Germany. Pim Gal's co-authors include Nassir Marrouche, Arif Elvan, Jaap Jan J. Smit, Anand R. Ramdat Misier, A. Adiyaman, Jan A. Staessen, Ahmet Adiyaman, Jacobus Burggraaf, Peter Paul H.M. Delnoy and Adam F. Cohen and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Pim Gal

57 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pim Gal Netherlands 14 529 76 62 51 50 60 771
Tatsuya Kawasaki Japan 13 540 1.0× 61 0.8× 123 2.0× 46 0.9× 38 0.8× 87 686
Christopher Hohmann Germany 10 212 0.4× 82 1.1× 57 0.9× 45 0.9× 14 0.3× 42 597
Lucy Barone Italy 14 318 0.6× 100 1.3× 118 1.9× 54 1.1× 59 1.2× 39 492
Tina Shiang United States 12 179 0.3× 111 1.5× 58 0.9× 36 0.7× 35 0.7× 19 729
Bálint András Barta Hungary 14 290 0.5× 42 0.6× 93 1.5× 128 2.5× 91 1.8× 37 542
S. Pavlović Serbia 18 295 0.6× 76 1.0× 92 1.5× 115 2.3× 17 0.3× 76 817
Petri Tuomainen Finland 14 348 0.7× 63 0.8× 206 3.3× 97 1.9× 32 0.6× 28 564
Andrej Teren Germany 14 221 0.4× 34 0.4× 105 1.7× 113 2.2× 87 1.7× 33 564
Justin T. Saunders United States 2 454 0.9× 155 2.0× 147 2.4× 91 1.8× 50 1.0× 2 755
Andrea Grandi Italy 13 174 0.3× 31 0.4× 32 0.5× 47 0.9× 45 0.9× 35 376

Countries citing papers authored by Pim Gal

Since Specialization
Citations

This map shows the geographic impact of Pim Gal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pim Gal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pim Gal more than expected).

Fields of papers citing papers by Pim Gal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pim Gal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pim Gal. The network helps show where Pim Gal may publish in the future.

Co-authorship network of co-authors of Pim Gal

This figure shows the co-authorship network connecting the top 25 collaborators of Pim Gal. A scholar is included among the top collaborators of Pim Gal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pim Gal. Pim Gal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gal, Pim, W. Bakker, Geert Jan Groeneveld, et al.. (2024). Open-Label Interventional Study in Healthy Volunteers to Evaluate NO-Mediated Vasodilation by Dermal Allyl Isothiocyanate Challenge and Whole-Body Heat Stress. Journal of Experimental Pharmacology. Volume 16. 285–294. 1 indexed citations
2.
Eggink, Hannah M., Ines Warnke, Sabina Bijlsma, et al.. (2024). Impact of fibre supplementation on microbiome and resilience in healthy participants: A randomized, placebo-controlled clinical trial. Nutrition Metabolism and Cardiovascular Diseases. 34(6). 1416–1426. 5 indexed citations
3.
Pereira, D., Luciana Summo, Anne Konkel, et al.. (2023). Identification of peripheral vascular function measures and circulating biomarkers of mitochondrial function in patients with mitochondrial disease. Clinical and Translational Science. 16(7). 1258–1271. 4 indexed citations
4.
Düngen, Hans‐Dirk, Frank Donath, Rainard Fuhr, et al.. (2023). Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes. American Journal of Cardiovascular Drugs. 23(2). 145–155. 9 indexed citations
5.
Doll, Robert J., Gerard J. P. van Westen, Adam F. Cohen, et al.. (2022). Cardiac age detected by machine learning applied to the surface ECG of healthy subjects: Creation of a benchmark. Journal of Electrocardiology. 72. 49–55. 10 indexed citations
6.
Grievink, Hendrika W., Pim Gal, Christoph J. Binder, et al.. (2022). Cardiovascular risk factors: The effects of ageing and smoking on the immune system, an observational clinical study. Frontiers in Immunology. 13. 968815–968815. 10 indexed citations
7.
8.
Gal, Pim, Jacobus Burggraaf, John Powell, et al.. (2020). A randomized controlled trial with a delayed‐type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man. British Journal of Clinical Pharmacology. 87(4). 1953–1962. 11 indexed citations
9.
10.
Heuberger, Jules A. A. C., Joris I. Rotmans, Pim Gal, et al.. (2017). Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial. The Lancet Haematology. 4(8). e374–e386. 36 indexed citations
11.
Gal, Pim, Jan Paul Ottervanger, Jaap Jan J. Smit, et al.. (2016). Association between pulmonary vein orientation and ablation outcome in patients undergoing multi-electrode ablation for atrial fibrillation. Journal of cardiovascular computed tomography. 10(3). 251–257. 7 indexed citations
12.
Gal, Pim, André C. Linnenbank, Ahmet Adiyaman, et al.. (2015). Correlation of atrial fibrillation cycle length and fractionation is associated with atrial fibrillation free survival. International Journal of Cardiology. 187. 208–215. 2 indexed citations
13.
Gal, Pim, Fatma Demirel, A. Adiyaman, et al.. (2015). Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation. Netherlands Heart Journal. 23(9). 430–435. 6 indexed citations
14.
Gal, Pim & Nassir Marrouche. (2015). Magnetic resonance imaging of atrial fibrosis: redefining atrial fibrillation to a syndrome. European Heart Journal. 38(1). 14–19. 94 indexed citations
15.
Gal, Pim, Jaap Jan J. Smit, Ahmet Adiyaman, et al.. (2015). A new circular mapping-guided approach for endoscopic laser balloon pulmonary vein isolation. IJC Heart & Vasculature. 8. 68–72. 2 indexed citations
16.
Gal, Pim, Joris F. Ooms, Jan Paul Ottervanger, et al.. (2015). Pulmonary vein orientation assessment: Is it necessary in patients undergoing contact force sensing guided radiofrequency catheter ablation of atrial fibrillation. IJC Heart & Vasculature. 8. 1–5. 4 indexed citations
17.
Gal, Pim, Jaap Jan J. Smit, & Arif Elvan. (2015). Endoscopically visible steam pop during high-energy laser pulmonary vein ablation. Netherlands Heart Journal. 23(9). 451–452. 1 indexed citations
18.
Gal, Pim, Jaap Jan J. Smit, A. Adiyaman, et al.. (2014). First Dutch experience with the endoscopic laser balloon ablation system for the treatment of atrial fibrillation. Netherlands Heart Journal. 23(2). 96–99. 15 indexed citations
19.
20.
Gal, Pim, et al.. (1990). Altered heparin pharmacodynamics in pulmonary embolism. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsuya Kawasaki Breakdown of academic impact, for papers by Christopher Hohmann Breakdown of academic impact, for papers by Lucy Barone Breakdown of academic impact, for papers by Tina Shiang Breakdown of academic impact, for papers by Bálint András Barta Breakdown of academic impact, for papers by S. Pavlović Breakdown of academic impact, for papers by Petri Tuomainen Breakdown of academic impact, for papers by Andrej Teren Breakdown of academic impact, for papers by Justin T. Saunders Breakdown of academic impact, for papers by Andrea Grandi
Rankless by CCL
2026